1. Stephen Abedon,Sarah Kuhl,Bob Blasdel,Elizabeth Kutter (2011). Phage treatment of human infections. Bacteriophage, 1(2), 66-85.
2. Stephen Abedon,Cameron Thomas-Abedon (2010). Phage Therapy Pharmacology. Current Pharmaceutical Biotechnology, 11(1), 28-47.
3. Suhail Ahmad (2010). New approaches in the diagnosis and treatment of latent tuberculosis infection. Respiratory Research, 11(1), 169-185.
4. J Caminero,G Sotgiu,A Zumla,G Migliori (2010). Best drug treatment for multidrugresistant and extensively drug-resistant tuberculosis. Lancet Infect. Dis, 10, 621-629.
5. Rebekah Dedrick,Carlos Guerrero-Bustamante,Rebecca Garlena,Daniel Russell,Katrina Ford,Kathryn Harris,Kimberly Gilmour,James Soothill,Deborah Jacobs-Sera,Robert Schooley,Graham Hatfull,Helen Spencer (2019). Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nature Medicine, 25(5), 730-733.
6. J Dinnes,J Deeks,H Kunst,A Gibson,E Cummins,N Waugh,F Drobniewski,A Lalvani (2007). A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technology Assessment, 11(3), 1-196.
7. V Gondil,S Chhibber (2018). Exploring potential of phage therapy for tuberculosis using model organism. Biomed. Biotechnol. Res. J, 2, 9-15.
8. Shuliang Guo,A Zhi (2012). Phage in the diagnosis and treatment of tuberculosis. Frontiers in Bioscience, 17(7), 2691.
9. Graham Hatfull (2014). Mycobacteriophages: Windows into Tuberculosis. PLoS Pathogens, 10(3), e1003953.
10. G Hatfull (2012). The secret lives of mycobacteriophages. Adv. Virus Res, 82, 179288.
11. V Leimane,V Riekstina,T Holtz,E Zarovska,V Skripconoka,L Thorpe,K Laserson,C Wells (2005). Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet, 365, 318-326.
12. D Lin,B Koskella,H Lin (2017). Phage therapy: An alternative to antibiotics in the age of multidrug-resistance. World J. Gastrointest. Pharmacol. Ther, 8(3), 162-173.
13. P Li,L Yong-Ai,C Bao Wen,L Youlun,S Xiaobing,S Cheng,W Guozhi (2009). Therapeutic effect of bacteriophage D29 in the treatment for 26: Growth curve of M.smeg in the presence of phage Figure guinea pigs infected with sensitive strain of Mycobacterium tuberculosis. Chinese J of Zoonoses, 25(08), 733-736.
14. Shigenobu Matsuzaki,Mohammad Rashel,Jumpei Uchiyama,Shingo Sakurai,Takako Ujihara,Masayuki Kuroda,Shosuke Imai,Masahiko Ikeuchi,Toshikazu Tani,Mikiya Fujieda,Hiroshi Wakiguchi (2005). Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. Journal of Infection and Chemotherapy, 11(5), 211-219.
15. C Merril,B Biswas,R Carlton,N Jensen,G Creed,S Zullo,S Adhya (1996). Long-circulating bacteriophage as antibacterial agents. Proceedings of the National Academy of Sciences, 93(8), 3188-3192.
16. J Pereira,H David,N Rastogi (1983). Isolation and partial characterization of temperaturesensitive mutants of the mycobacteriophage D29. Virologie, 134, 33-49.
17. Welkin Pope,Christina Ferreira,Deborah Jacobs-Sera,Robert Benjamin,Ariangela Davis,Randall Dejong,Sarah Elgin,Forrest Guilfoile,Mark Forsyth,Alexander Harris,Samuel Harvey,Lee Hughes,Peter Hynes,Arrykka Jackson,Marilyn Jalal,Elizabeth Macmurray,Coreen Manley,Molly Mcdonough,Jordan Mosier,Larissa Osterbann,Hannah Rabinowitz,Corwin Rhyan,Daniel Russell,Margaret Saha,Christopher Shaffer,Stephanie Simon,Erika Sims,Isabel Tovar,Emilie Weisser,John Wertz,Kathleen Weston-Hafer,Kurt Williamson,Bo Zhang,Steven Cresawn,Paras Jain,Mariana Piuri,William Jacobs,Roger Hendrix,Graham Hatfull (2011). Cluster K Mycobacteriophages: Insights into the Evolutionary Origins of Mycobacteriophage TM4. PLoS ONE, 6(10), e26750.
18. S Samaddar,R Grewal,S Sinha,S Ghosh,S Roy,S Das Gupta (2016). Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host Lethality. Appl. Environ. Microbiol, 82(1), 124-133.
19. Rajitha Satish,Anita Desouza (2019). Study of characteristics of mycobacteriophage – A novel tool to treat Mycobacterium spp. International Journal of Mycobacteriology, 8(2), 170.
20. R Satish,A Desouza (2018). Isolation of Mycobacteriophage Novel tool to treat Mycobacterium spp. International Journal of Scientific Research in Biological Sciences, 5(2), 46-50.
21. N Shah,Abigail Wright,Gill-Han Bai,Lucia Barrera,Fadila Boulahbal,Nuria Martín-Casabona,Francis Drobniewski,Chris Gilpin,Marta Havelková,Rosario Lepe,Richard Lumb,Beverly Metchock,Françoise Portaels,Maria Rodrigues,Sabine Rüsch-Gerdes,Armand Van Deun,Veronique Vincent,Kayla Laserson,Charles Wells,J Cegielski (2007). Worldwide Emergence of Extensively Drug-resistant Tuberculosis. Emerging Infectious Diseases, 13(3), 380-387.
22. Alexander Sulakvelidze,Zemphira Alavidze,J Morris (2001). Bacteriophage Therapy. Antimicrobial Agents and Chemotherapy, 45(3), 649-659.
23. Yasunori Tanji,Takuya Shimada,Hiroshi Fukudomi,Kazuhiko Miyanaga,Yutaka Nakai,Hajime Unno (2005). Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice. Journal of Bioscience and Bioengineering, 100(3), 280-287.
24. Y Tanji,T Shimada,M Yoichi,K Miyanaga,K Hori,H Unno (2004). Toward rational control of Escherichia coli O157:H7 by a phage cocktail. Applied Microbiology and Biotechnology, 64(2), 270-274.
25. Christal Vitiello,Carl Merril,Sankar Adhya (2005). An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a 1000-fold. Virus Research, 114(1-2), 101-103.